Elspar and Heart attack - a phase IV clinical study of FDA data


Heart attack is found among people who take Elspar, especially for people who are female, 30-39 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Elspar and have Heart attack. It is created by eHealthMe based on reports of 2,053 people who have side effects when taking Elspar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 03, 2022

2,053 people reported to have side effects when taking Elspar.
Among them, 7 people (0.34%) have Heart attack.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users for its effectiveness, alternative drugs and more.

What is Heart attack?

Heart attack is found to be associated with 3,628 drugs and 3,114 conditions by eHealthMe.

Number of Elspar and Heart attack reports submitted per year:

Could Elspar cause Heart attack?

Time on Elspar when people have Heart attack *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Heart attack when taking Elspar *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Heart attack when taking Elspar *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 0.0 %
  • 30-39: 71.43 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 0.0 %

Common drugs people take besides Elspar *:

  1. Campath: 5 people, 71.43%
  2. Methotrexate: 5 people, 71.43%
  3. Dexamethasone: 5 people, 71.43%
  4. Voriconazole: 3 people, 42.86%
  5. Famciclovir: 3 people, 42.86%
  6. Bactrim: 3 people, 42.86%
  7. Compazine: 3 people, 42.86%
  8. Cyclophosphamide: 3 people, 42.86%
  9. Megace: 3 people, 42.86%
  10. Meropenem: 3 people, 42.86%

Common side effects people have besides Heart attack *:

  1. Pneumonia: 5 people, 71.43%
  2. Myositis (inflammation of the muscles): 5 people, 71.43%
  3. Cerebral Haemorrhage (bleeding within the brain): 5 people, 71.43%
  4. White Blood Cell Count Abnormal: 3 people, 42.86%
  5. Systemic Mycosis (fungal infections of the body): 3 people, 42.86%
  6. Platelet Disorder: 3 people, 42.86%
  7. Multi-Organ Failure (multisystem organ failure): 2 people, 28.57%
  8. Ventricular Extrasystoles (premature cardiac contraction): 1 person, 14.29%
  9. Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 1 person, 14.29%
  10. Pulmonary Haemorrhage (acute bleeding from the lung): 1 person, 14.29%

Common conditions people have *:

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 71.43%

* Approximation only. Some reports may have incomplete information.

Do you take Elspar and have Heart attack?

Check whether Heart attack is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Heart attack and when was it recovered:

Expand to all the drugs that have ingredients of asparaginase:

Alternative drugs to, pros and cons of Elspar:

Common Elspar side effects:

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Heart attack treatments and more:

COVID vaccines that are related to Heart attack:

Common drugs associated with Heart attack:

All the drugs that are associated with Heart attack:

Common conditions associated with Heart attack:

All the conditions that are associated with Heart attack:

How the study uses the data?

The study uses data from the FDA. It is based on asparaginase (the active ingredients of Elspar) and Elspar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: